Seafood CRC: research, develop and trial new Australian wild caught abalone products in China
This project has been developed following the discovery of a number of issues in the direct supply of the product to the China market during the progress of current project 2009/723. These, if not addressed, pose a risk to the sustainable success of this market development initiative. However, the scope to fix these problems is outside the scope of the current project.
The specific issues that need addressing are:
1. The current wild caught abalone product being supplied to the trial restaurants of the program is not always presented to support the premium positioning. There appear to be issues with current processes and packaging that affect the product quality that have been seen by the project team during market reviews in China. Inconsistency in product quality heightens regulatory and customer scrutiny of quality and safety parameters.
- The project will provide technical expertise and experimental support to assist current suppliers in optimising raw materials, labour, equipment and packaging and to develop a quality criteria system to supply product that meets the premium positioning in the current project.
2. There is currently a low level of engagement between the importers and the end user and consumer (restaurants and their customers). As the current project builds customer relationships, we have the opportunity to work closely with them to:
- supply the technical requirements to ensure that authentic, safe quality products (current and new) are available through the direct supply channel to China.
- develop new products variants based on direct end user feedback on what are required for the market. Development of new products and a market for them will help remove the price volatility and supply issues associated with a mainly live market and overcome one of the barriers to having Australian wild caught abalone on premium restaurant menus.
Seafood CRC: market access for abalone - biotoxins
In 2010 marine biotoxins are being targeted by Chinese and Japanese authorities for import testing of Australian shellfish, including abalone. Australia is a major exporter of ‘wild caught’ abalone, with over 50 % of Australian abalone caught in 2008 exported to Hong Kong and China, therefore the results and cost of these import testing regimes can have a significant impact on this trade.
Codex are progressing an international abalone standard with proposed marine biotoxin testing components. These standards could require Australia to intensively sample abalone from the coast line and would have large cost implications for industry.
The EU have reduced requirements for biotoxins in abalone, however some end product testing of abalone for biotoxins is still required for access and this imposes additional cost on industry.
The proposed project involves testing of wild caught abalone for biotoxins. The core purpose of the data collected in the project is to improve the quality of the risk assessment. This risk assessment can then be used to support:
- negotiations towards risk based biotoxin testing requirements in the international Codex standard, and
- reduced testing requirements for abalone going to China, Japan and the EU (e.g. aim for no end product testing).
The project will also provide scientific information to support risk management strategies to assist in decision making if biotoxins ever do become an issue for abalone in Australia.
An objective in the strategic plan of the Abalone Council of Australia (ACA) is to “Determine the product quality and integrity parameters specific to each product type”. In relation to this objective, the ACA have strongly supported the development of this project, which aims to determine the quality of abalone with respect to marine biotoxins and will underpin future negotiations on international requirements for biotoxins in abalone.
Final report
Seafood CRC: overseas market access for shellfish
The potential reduction of regulatory thresholds for marine biotoxins in the EU will have significant negative economic consequences for the Australian oyster, mussel, scallop and abalone industries (and pipi’s if domestic regulatory thresholds also changed).
The scallop, oyster and mussel industry currently export product to the EU. Total scallop exports to the EU in 2006/2007 were valued at around $4,551,000 AUD (187 t). Other mollusc (including oysters and mussels) exports to the EU in 2006/2007 were around $1,084,000 AUD (255 t). Due to the periodic occurrence of okadaic acid toxins and saxitoxins in Australian shellfish the implementation of reduced regulatory levels would reduce the amount of product eligible for export to the EU.
Exports of Australian abalone to the EU ceased in 2007, this was in part due to the enforcement of marine biotoxin regulatory limits by the EC. The wild caught abalone industry is attempting to regain market access to the EU through determining alternate risk management procedures for marine biotoxins in abalone. The reduction of regulatory levels for marine biotoxins may impinge on future EU access arrangements for Australian abalone.
Experience has repeatedly demonstrated that European decisions can impact on other more commercially significant markets, including Asia and the domestic market. Codex may also be prompted to change marine biotoxin guidance levels in response to EU changes. Wide spread adoption of reduced regulatory levels for marine biotoxins would result in increased growing area closures in Australia and less product eligible for sale. This proposal aims to assist in maintaining the current EU regulatory limits for marine biotoxins which will allow the current amount of shellfish to be exported to the EU and avoid other markets being influenced.
Final report
The oyster, scallop and mussel industries currently export product to the EU. Due to the periodic occurrence of Okadaic Acid (OA) and Saxitoxin (STX) group toxins in Australian shellfish the implementation of reduced regulatory levels would reduce the amount of product eligible for EU export. Exports of Australian abalone to the EU ceased in 2007, due in part to the enforcement of marine biotoxin regulatory limits set by the EC. The wild caught abalone industry is attempting to regain EU market access through determining alternate risk management procedures for marine biotoxins in abalone.
The European Commission (EC) requested the European Food Safety Authority (EFSA) to assess the current European Union (EU) limits for shellfish regarding human health and methods of analysis for various marine biotoxins, including newly emerging toxins. A critical recommendation of the ‘EFSA Opinions’ is that the regulatory limits should be significantly lower (more stringent) for both OA and STX.
The objectives of this study were to:
- Undertake a robust technical review of the EFSA risk assessments on STX and OA group toxins.
- Submit the technical review and a rationale for maintaining current marine biotoxin regulatory limits to the EC.
- Convene a working group to determine future steps required to mitigate potential lowering of marine biotoxin regulatory limits.